Company Vcanbio Cell & Gene Engineering Corp., Ltd

Equities

600645

CNE000000545

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

VCANBIO CELL & GENE ENGINEERING CORP., LTD

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
16.97 ^CNY	+3.16%		+10.05%	-16.28%

Apr. 25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 25	Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

VCANBIO CELL & GENE ENGINEERING CORP., LTD is a China-based company, principally engaged in the preparation, detection and storage of cells. The Company is also engaged in cell culture and gene detection and storage, as well as the production and sale of cytokines culture solutions, cosmetics and detection reagents. The Company conducts its businesses mainly within domestic markets.

Number of employees: 2,332

CNY in Million	2021	Weight	2022	Weight	Delta
Reagents and Medical Equipment 66.4 %	934	60.9 %	1,033	66.4 %	+10.56%
Stem Cell-related Business 33.6 %	563	36.7 %	522	33.6 %	-7.32%

CNY in Million	2021	Weight	2022	Weight	Delta
China 76.8 %	321	21.5 %	1,155	76.8 %	+260.21%
Overseas 23.2 %	1,171	78.5 %	348	23.2 %	-70.26%

Managers	Title	Age	Since
Yong Wang CEO	Chief Executive Officer	57	09-06-29
Xiao Ting Wang DFI	Director of Finance/CFO	42	22-05-24
Hai Bin Li BRD	Director/Board Member	53	16-01-31
Xu Li BRD	Director/Board Member	39	18-12-02
Fen Zhang IRC	Investor Relations Contact	-	-
Xin Zhe Yang SEC	Corporate Secretary	51	18-11-15

Members of the board	Title	Age	Since
Hong Jia Gong CHM	Chairman	59	22-03-25
Yong Wang CEO	Chief Executive Officer	57	09-06-29
Xin Yi Hou BRD	Director/Board Member	64	20-05-18
Yan Wang CHM	Chairman	53	23-05-15
Hong Qi Wang BRD	Director/Board Member	59	23-05-15
Hai Bin Li BRD	Director/Board Member	53	16-01-31
Shan Wu BRD	Director/Board Member	43	18-12-02
Duan Qing Pei BRD	Director/Board Member	59	20-05-18
Xin Tong Li BRD	Director/Board Member	30	23-05-15
Li Tianyi BRD	Director/Board Member	36	23-05-15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	471,418,790	337,719,549 ( 71.64 %)	3,469,900 ( 0.7361 %)	71.64 %

Name	Equities	%	Valuation
De Fu Li 12.20 %	57,078,420	12.20 %	130 M ¥
Shenzhen Jiadaogu Investment Management Co. Ltd. 9.608 %	44,943,820	9.608 %	102 M ¥
China Cinda Asset Management Co., Ltd. (Investment Company) 4.746 %	22,200,000	4.746 %	50 M ¥
UBS Asset Management Switzerland AG 2.534 %	11,851,764	2.534 %	27 M ¥
Hui Wang 1.381 %	6,457,900	1.381 %	15 M ¥
Chun Mei Chen 1.232 %	5,761,349	1.232 %	13 M ¥
Qian Qian Yang 0.9415 %	4,404,200	0.9415 %	10 M ¥
Yulong Ma 0.7641 %	3,574,000	0.7641 %	8 M ¥
Xiao Ge Wang 0.7631 %	3,569,785	0.7631 %	8 M ¥
Zhi Lin Xu 0.6943 %	3,247,863	0.6943 %	7 M ¥

Vcanbio Cell & Gene Engineering Corp., Ltd.

Huayuan Industrial Park 12 Meiyuan Road

300384, Tianjin

+86 22 5877 5766

http://www.vcanbio.com

address Vcanbio Cell & Gene Engineering Corp., Ltd(600645)

Name	Category and Sector
Tianjin Yuanjufu Enterprise Management Partnership (LP)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
VCANBIO CELL & GENE ENGINEERING CORP., LTD	-16.28%	1.06B
BIOMÉRIEUX	+1.69%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7.57%	7.61B
DIASORIN S.P.A.	+3.22%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.93%	4.51B
LANTHEUS HOLDINGS, INC.	+8.48%	4.49B
ANDON HEALTH CO., LTD.	+9.21%	2.73B
VITROLIFE AB	-13.87%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.63%	1.73B
MYRIAD GENETICS, INC.	+3.45%	1.64B

Diagnostic & Testing Substances